Jithma P Abeykoon Selected Research

choline salicylate

1/2021

Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jithma P Abeykoon Research Topics

Disease

10	Neoplasms (Cancer) 04/2024 - 01/2021
8	Waldenstrom Macroglobulinemia (Macroglobulinemia) 03/2024 - 01/2017
5	Multiple Myeloma 10/2022 - 11/2017
5	Lymphoma (Lymphomas) 10/2021 - 01/2017
4	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 10/2023 - 12/2020
3	Erdheim-Chester Disease 10/2023 - 11/2020
3	Disease Progression 01/2020 - 01/2018
2	COVID-19 04/2024 - 06/2023
2	Infections 04/2024 - 04/2021
2	Paraproteinemias (Monoclonal Gammopathy) 12/2023 - 01/2022
2	Sinus Histiocytosis (Rosai-Dorfman Disease) 10/2023 - 12/2022
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 01/2021
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 01/2018
2	Immunoglobulin Light-chain Amyloidosis 01/2019 - 01/2017
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2024
1	Carcinogenesis 12/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Histiocytic Sarcoma 01/2023
1	Histiocytosis 12/2022
1	Toxic Optic Neuropathy 10/2022
1	Langerhans Cell Sarcoma 01/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2021
1	Sepsis (Septicemia) 04/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Macroglossia 01/2018
1	Amyloidosis 01/2018
1	Transthyretin-Related Hereditary Amyloidosis 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Long Term Adverse Effects 01/2018

Drug/Important Bio-Agent (IBA)

5	Immunoglobulin M (IgM)IBA 12/2023 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2021
3	Rituximab (Mabthera)FDA Link 08/2023 - 10/2017
3	Dexamethasone (Maxidex)FDA LinkGeneric 08/2018 - 10/2017
2	CytokinesIBA 04/2024 - 06/2023
2	Agammaglobulinaemia Tyrosine KinaseIBA 03/2024 - 08/2023
2	ibrutinibIBA 10/2021 - 01/2020
2	daratumumabIBA 01/2019 - 11/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2018 - 10/2017
1	Long Noncoding RNAIBA 12/2023
1	MicroRNAs (MicroRNA)IBA 12/2023
1	Muramidase (Lysozyme)IBA 10/2023
1	Factor XIIIaIBA 10/2023
1	serum P-component (CIt)IBA 08/2023
1	Glycoproteins (Glycoprotein)IBA 06/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	trastuzumab deruxtecanIBA 01/2023
1	Sirolimus (Rapamycin)FDA Link 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2022
1	cobimetinibIBA 12/2022
1	B-Cell Maturation AntigenIBA 10/2022
1	belantamab mafodotinIBA 10/2022
1	Immunoconjugates (Immunoconjugate)IBA 10/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	pembrolizumabIBA 01/2022
1	pexidartinibIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 04/2021
1	SalicylatesIBA 01/2021
1	Cladribine FDA LinkGeneric 01/2021
1	selinexorIBA 01/2021
1	MagnesiumIBA 01/2021
1	choline salicylateIBA 01/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	VemurafenibIBA 11/2020
1	AlbuminsIBA 01/2019
1	Bendamustine Hydrochloride FDA Link 08/2018
1	Proteasome InhibitorsIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Prealbumin (Transthyretin)IBA 01/2018
1	Immunomodulating AgentsIBA 01/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	Lenalidomide (CC 5013)FDA Link 11/2017
1	Bortezomib (Velcade)FDA Link 11/2017
1	pomalidomideIBA 11/2017
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2017

Therapy/Procedure

17	Therapeutics 04/2024 - 11/2017
2	Stem Cell Transplantation 01/2021 - 01/2021
1	Aftercare (After-Treatment) 12/2022
1	Drug Tapering 10/2022
1	Radiotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2018